• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为加拿大心力衰竭患者降低自付药物费用的策略。

Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure.

机构信息

Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

Cardiovasc Drugs Ther. 2021 Oct;35(5):1009-1023. doi: 10.1007/s10557-020-07046-1. Epub 2020 Aug 17.

DOI:10.1007/s10557-020-07046-1
PMID:32803405
Abstract

INTRODUCTION

Daily medication is the cornerstone of evidence-based therapy to reduce mortality and morbidity in patients with heart failure (HF). Up to 20% of Canadian patients pay for medications out of pocket. We sought to identify strategies that patients and prescribers can employ to reduce these costs.

METHODS

We collected data from outpatient pharmacies in Hamilton, Ontario. We determined prices for different medications in each of the drug classes recommended for HF with reduced ejection fraction in the Canadian Cardiovascular Society's guidelines. We examined differences in dispensing and delivery fees and inquired about other cost-saving strategies.

RESULTS

We collected data from 24 different pharmacies, including a selection of hospital-based, independent, and larger chain pharmacies. In the most extreme scenario (i.e., 90-day prescription instead of a 30-day prescription and the least expensive generic drug instead of the most expensive brand name drug), total medication costs can differ by up to $495.56 per month. Costs were affected by choice of agent within a drug class, generic versus brand-name drug, quantity dispensed, dispensing fee, and delivery cost.

CONCLUSIONS

Prescription content, dispensing practice, and pharmacy choice can remarkably impact out-of-pocket costs for HF medications. Prescribers can reduce costs by writing 90-day prescriptions and choosing the lowest-cost generic drugs in each therapeutic class. Patients should consider the services received for their pharmacy dispensing fees, use free delivery services where needed, and request inexpensive generic drugs. Pharmacists can facilitate cost minimization without compromising therapeutic efficacy.

摘要

简介

每日用药是降低心力衰竭(HF)患者死亡率和发病率的循证治疗的基石。多达 20%的加拿大患者需要自费购买药物。我们试图确定患者和处方者可以采用的策略来降低这些成本。

方法

我们从安大略省汉密尔顿的门诊药房收集数据。我们确定了加拿大心血管学会指南中推荐用于射血分数降低的心力衰竭的不同药物类别中每种药物的价格。我们检查了配药和配送费用的差异,并询问了其他节省成本的策略。

结果

我们从 24 家不同的药房收集了数据,其中包括一些医院附属、独立和较大连锁药房的选择。在最极端的情况下(即,90 天的处方而不是 30 天的处方,以及最便宜的仿制药而不是最贵的品牌药),每月的总药物费用可能相差高达 495.56 加元。成本受到药物类别内的药物选择、仿制药与品牌药、配药量、配药费用和配送成本的影响。

结论

处方内容、配药实践和药房选择可以显著影响 HF 药物的自费成本。医生可以通过开具 90 天的处方并选择每个治疗类别中最便宜的仿制药来降低成本。患者应考虑其药房配药费用所获得的服务,在需要时使用免费配送服务,并要求提供廉价的仿制药。药剂师可以在不影响治疗效果的情况下促进成本最小化。

相似文献

1
Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure.为加拿大心力衰竭患者降低自付药物费用的策略。
Cardiovasc Drugs Ther. 2021 Oct;35(5):1009-1023. doi: 10.1007/s10557-020-07046-1. Epub 2020 Aug 17.
2
Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease.降低加拿大外周动脉疾病患者自付药物费用的策略。
Can J Surg. 2024 Jan 3;67(1):E1-E6. doi: 10.1503/cjs.003722. Print 2024 Jan-Feb.
3
Impact of brand drug discount cards on private insurer, government and patient expenditures.品牌药折扣卡在私人保险公司、政府和患者支出方面的影响。
CMAJ. 2019 Nov 11;191(45):E1237-E1241. doi: 10.1503/cmaj.190098.
4
[Cost of drugs used to treat cardiovascular disease in Brazil].[巴西用于治疗心血管疾病的药物成本]
Rev Panam Salud Publica. 2012 Jan;31(1):62-7. doi: 10.1590/s1020-49892012000100009.
5
Comparison of Discounted and Undiscounted Cash Prices for Cardiovascular Medications by Type of US Community Pharmacy.美国社区药店按心血管药物类型划分的折扣现金价格与非折扣现金价格比较。
J Gen Intern Med. 2021 Jan;36(1):114-120. doi: 10.1007/s11606-020-06149-7. Epub 2020 Sep 3.
6
Do generics offer significant savings to the UK National Health Service?仿制药能为英国国民医疗服务体系大幅节省开支吗?
Curr Med Res Opin. 2007 Jan;23(1):105-16. doi: 10.1185/030079907X159506.
7
Undocumented source of pharmacy benefit manager revenue.药品福利管理公司收入的不明来源。
Am J Health Syst Pharm. 2008 Mar 15;65(6):552-7. doi: 10.2146/ajhp070389.
8
Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.通过4美元通用药物折扣计划可获得的通用心血管药物的医疗保险受益人的自付费用。
Ann Intern Med. 2018 Dec 4;169(11):817-819. doi: 10.7326/M18-0965. Epub 2018 Jul 24.
9
The association of insurance type with costs of dispensed drugs.保险类型与配药费用的关联。
Inquiry. 1998 Spring;35(1):23-35.
10
Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.第三方报销仿制药:在最高限价成本报销环境下,低于成本的报销盛行。
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4):421-425. doi: 10.1016/j.japh.2018.04.018. Epub 2018 May 31.

引用本文的文献

1
Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease.降低加拿大外周动脉疾病患者自付药物费用的策略。
Can J Surg. 2024 Jan 3;67(1):E1-E6. doi: 10.1503/cjs.003722. Print 2024 Jan-Feb.
2
Strategies for reducing out of pocket payments in the health system: a scoping review.卫生系统中减少自付费用的策略:一项范围综述
Cost Eff Resour Alloc. 2021 Aug 4;19(1):47. doi: 10.1186/s12962-021-00301-8.